Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Sui (SUI) Price & Performance

Price performance (Past 24H)

Key statistics

Injective vs Sui — how do they compare? Injective trades at Rp78,615 (market cap Rp7,83T, Rp673,83M 24h volume), while Sui trades at Rp12,079 (market cap Rp48,99T, Rp2,19T 24h volume). The key difference: Sui is far larger — about 6.3× Injective's market cap, and Sui's supply is capped (4,1B / 10B SUI (41%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and Sui for 37 Days on average.

INJSUI
Market Cap
Rp7,83TRp48,99T
Volume (24h)
Rp673,83MRp2,19T
Circulating Supply
100M INJ4,1B / 10B SUI (41%)
Typical Hold Time
37 Days37 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.

Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.

Sui

Sui is currently trading at Rp12,306 with a market cap of Rp50.06T, showing a bearish technical signal overall. The asset has 41% circulating supply with a 37-day average hold time. Technical indicators show mixed signals with moving averages bearish but oscillators neutral. Recent ecosystem developments include strategic partnerships expanding token utility and lending activities on the Sui blockchain.

Overall outlook remains cautious with bearish technical pressure but neutral momentum. Key opportunities include growing ecosystem partnerships and expanding DeFi integration. Major risks include high volatility, regulatory uncertainty, and the asset trading near pivot point resistance levels.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
53% Buy47% Sell
Avg holding period · 37 Days
SUI
42% Buy58% Sell
Avg holding period · 37 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Sui

Sui is a first-of-its-kind Layer-1 blockchain and smart contract platform designed from the bottom up to make digital asset ownership fast, private, secure, and accessible to everyone. Based on the Move programming language, its object-centric model enables parallel execution, sub-second finality, and rich on-chain assets. Sui supports a wide range of applications with unrivaled speed at a low cost.

Read more on SUI